Irnocam 40 Injection

Irnocam 40 mg Injection is classified as an anti-cancer medication, also known as a cytostatic. Its active component is Irinotecan hydrochloride trihydrate. This medication is indicated for the treatment of advanced colon and rectal cancer in adults. It may be administered alone or in conjunction with other chemotherapy drugs.

Colon and rectal cancers are most commonly found in individuals over the age of 50, with their occurrence influenced by both genetic and environmental factors.

The most frequently reported side effects of Irnocam 40 mg Injection include myelosuppression (which results in reduced levels of red blood cells, white blood cells, and platelets) and diarrhea. Other notable side effects may include nausea, vomiting, abdominal discomfort, constipation, anemia, pain, fatigue, fever, infections such as sepsis, elevated bilirubin levels, hair loss, and weight reduction. It is important to notify your doctor if these side effects are bothersome or persist.

If you have a known allergy to Irnocam 40 mg Injection or any of its components, inform your physician. Prior to initiating treatment, disclose any history of liver issues or jaundice, kidney and heart conditions, asthma, hypertension, high cholesterol, or severe diarrhea to your healthcare provider. Additionally, if you smoke or have previously undergone radiation therapy, this should be communicated to your healthcare provider. Consult with your healthcare provider regarding any other medications, herbal products, or supplements you may be taking. It is crucial for both males and females to use effective contraception during treatment to prevent pregnancy. Your physician will conduct blood tests before and during treatment to monitor the medication’s impact on blood counts and chemistry.